We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Phase I Dosing for Cancer Drugs Detailed in New ICH Guidance
Phase I Dosing for Cancer Drugs Detailed in New ICH Guidance
February 20, 2009
Phase I clinical trials of cancer drugs can include maximum tolerated doses and dose-limiting toxicity, an International Conference on Harmonisation (ICH) draft guidance says.